Felbamate
- Product NDC
- 47781-627
- 11-digit product format
- 477810627
- Labeler code
- 47781
- Product ID
- 47781-627_72e80ec7-18d6-89f9-ed6f-8525606e19c1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- felbamate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Alvogen Inc.
- Application
- ANDA204595
- Marketing category
- ANDA
- Marketing start
- 2018-12-01
- Marketing end
- 0000-00-00
- Substance
- FELBAMATE
- Active strength
- 400 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 47781-627-01 | 47781062701 | 100 TABLET in 1 BOTTLE (47781-627-01) | 100 tablet | 2018-12-24 | 0000-00-00 | No | No | Current |